Access Vascular
Access Vascular was founded in 2015 to develop novel bulk hydrophilic-based devices to improve venous access.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD136—204m (Dealroom.co estimates Oct 2023.)
Billerica Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $1.2m | Seed | |
N/A | Grant | ||
$3.8m | Seed | ||
| N/A | $1.9m | Early VC | |
$3.4m | Early VC | ||
| N/A | $6.0m | Early VC | |
$20.0m | Series B | ||
* | N/A | $22.0m | Series C |
| Total Funding | AUD90.1m | ||
Related Content
Recent News about Access Vascular
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.